Medtronic Showcases Smart Medical Solutions at Global Digital Trade Expo Amid IPO Filing of Its Diabetes Spin-off

(Source: Economic Daily)

Source: Economic Daily

On September 25, the fourth Global Digital Trade Expo opened in Hangzhou. Medtronic showcased nearly 30 intelligent representative products and solutions at the exhibition. These innovative achievements are dedicated to providing personalized diagnosis and treatment as well as full-cycle disease management for doctors and patients.

Medtronic Global Senior Vice President and Greater China President, Gu Yushao, stated: "Artificial intelligence and digitalization are key forces in promoting healthcare equity and accessibility. Medtronic continuously upgrades its empowering products and solutions, actively integrates into the local value chain, and collaborates with local partners to achieve clinical breakthroughs in cutting-edge fields such as AI-assisted diagnosis and treatment, digital therapeutics, and telemedicine. Medtronic actively participates in national-level exhibitions like the Digital Trade Fair and the China International Import Expo, hoping to facilitate more cross-disciplinary exchanges and industry cooperation, and inspire more local innovations."

It is reported that at this Digital Trade Expo, Medtronic has brought innovative products and technologies covering areas such as cardiology and vascular, neuroscience, surgery, and diabetes.

At this Digital Trade Expo, Medtronic announced a strategic cooperation with Boea Wisdom, a local artificial intelligence technology company. Both parties will fully integrate their technical advantages to build a complete diagnosis and treatment chain covering the whole process.

Rooted in China for 36 years, Medtronic has grown into an important ecological co-creator in China's medical industry, deeply integrating "digital intelligence" into key segments of the local value chain, including R&D, production, sales, training, after-sales services, and investment. In March this year, Medtronic established its first Digital Healthcare Innovation Hub in China, focusing on developing disease management solutions based on artificial intelligence and big data. Collaborating with local innovative enterprises, clinical experts, and technology partners, the hub covers the entire process from foundational algorithms to clinical validation, jointly exploring and shaping new models of healthcare innovation. (Reported by Yuan Yong, Economic Daily)